Stay updated on BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Sign up to get notified when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.

Latest updates to the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page
- Check5 days agoChange DetectedThe page's revision label was updated to v3.5.5, replacing v3.5.4, indicating a new backend build rather than a substantive content change.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedLocation data on the study page were updated, adding corrected postal codes for Hong Kong and Sapporo and adjusting associated dates. This clarifies where the trial is conducted and how to contact the sites.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a site software/version change rather than a change to the trial information displayed.SummaryDifference0.0%

- Check55 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check63 days agoChange DetectedEnrollment (Actual) updated to 330 on 2026-04-08. The previous value 331 was removed on 2026-03-02.SummaryDifference0.1%

- Check84 days agoChange DetectedRecruitment status updated to Completed with new sites added (Emory University; Sapporo and Sendai in Japan). The prior Active, not recruiting status and an older site entry were removed, and the revision was updated to v3.5.0.SummaryDifference0.4%

Stay in the know with updates to BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Enter your email address, and we'll notify you when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.